Crossmark

Residual risk of clinically significant copy number variations in fetuses with ultrasonographic soft markers following exclusion of non-invasive prenatal screening-detectable findings

Crossref DOI link: https://doi.org/10.1007/s00404-026-08373-8

Published Online: 2026-03-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liang, Yixuan

Zhou, Ran

Liu, Tingting

Gao, Jie

Xu, Yiyun

Huang, Mingtao

Meng, Lulu

Huo, Haiqin

Zhang, Qinxin

Wu, Yun

Xu, Zhengfeng

Wang, Yan
Funding

Funding for this research was provided by:

Research Project of Jiangsu Province Association of maternal and Child Health (FYX202312)

National Key Research and Development Program of China (2022YFC2703400)
License Information

Text and Data Mining valid from 2026-03-18

Version of Record valid from 2026-03-18
More Information

Article History

Received: 20 November 2025

Accepted: 18 February 2026

First Online: 18 March 2026

Declarations

:

: The authors declare no competing interests.

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Medical Ethics Committee of Nanjing Women and Children’s Healthcare Hospital on the 8th February, 2025 (2025KY003-001).

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below